Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.3 USD | +1.35% | +0.27% | +30.48% |
19/04 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
01/04 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.48% | 228.86Cr | |
+8.69% | 8.5TCr | |
+4.02% | 7.74TCr | |
-13.71% | 5.39TCr | |
-22.61% | 4.76TCr | |
+24.87% | 4.66TCr | |
+19.76% | 4.28TCr | |
+63.60% | 3.7TCr | |
-9.93% | 2.46TCr | |
+18.48% | 2.17TCr |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- William Blair Upgrades Cellebrite DI to Outperform From Market Perform